Quick Answer
Instil Bio, Inc. reported Net Income Loss of -$71.37 million for the year ending 2025.
- Instil Bio, Inc. showed an increase of +3.7% in Net Income Loss from 2024 to 2025.
- This data is from Instil Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Instil Bio, Inc.'s Net Income Loss has declined by 89.1%.
- Historical annual values: Fiscal year 2025: -$71.37 million | Fiscal year 2024: -$74.14 million | Fiscal year 2023: -$156.09 million | Fiscal year 2022: -$223.18 million | Fiscal year 2021: -$156.79 million | Fiscal year 2020: -$37.74 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: